Expression of costimulatory molecules CD80 and CD86 and their receptors CD28, CTLA-4 on malignant ascites CD3+ tumour-infiltrating lymphocytes (TIL) from patients with ovarian and other types of peritoneal carcinomatosis
about
rIFN-gamma-mediated growth suppression of platinum-sensitive and -resistant ovarian tumor cell lines not dependent upon arginase inhibitionDysregulated expression of both the costimulatory CD28 and inhibitory CTLA-4 molecules in PB T cells of advanced cervical cancer patients suggests systemic immunosuppression related to disease progressionPotentially important microRNA cluster on chromosome 17p13.1 in primary peritoneal carcinoma.Modulation of immune response by B7 family molecules in tumor microenvironments.The impact of T-cell immunity on ovarian cancer outcomes.Immune suppression in tumors as a surmountable obstacle to clinical efficacy of cancer vaccinesSafety of mTOR inhibitors in breast cancer.Interaction Landscape of Inherited Polymorphisms with Somatic Events in Cancer.Ovarian carcinoma cells effectively inhibit differentiation and maturation of dendritic cells derived from hematopoietic progenitor cells in vitro.Abatacept (CTLA-4Ig) treatment reduces T cell apoptosis and regulatory T cell suppression in patients with rheumatoid arthritis.Resident Memory-Like Tumor-Infiltrating Lymphocytes (TIL): Latest Players in the Immuno-Oncology Repertoire
P2860
Q24805224-76CBFB91-71B2-456A-80EE-3FA2580B7C5AQ34633776-1737B044-F38B-4D2A-A175-D70B491E5BC7Q34803840-52AE4970-95A2-4A92-8FF4-D38A04C431D0Q36569007-78A688D5-7FF7-4C11-9F71-865543612D50Q37118142-321260D1-BEB0-475F-A44F-E1298DB56609Q37137360-E0425FFB-E06D-4938-8CF0-216DB1A59E53Q38841039-A2FAEC9D-1C82-4389-BE93-FDFD63C2AEB4Q38966664-C887E2E7-7B84-4638-B747-8D3E9B7015F7Q40367465-8D840171-1563-4522-83C3-AA06A2B30072Q52894906-2C2510ED-3604-4EB2-9B55-9AD73946773AQ57174538-71989191-E8CA-4500-8F4F-F874D488DC32
P2860
Expression of costimulatory molecules CD80 and CD86 and their receptors CD28, CTLA-4 on malignant ascites CD3+ tumour-infiltrating lymphocytes (TIL) from patients with ovarian and other types of peritoneal carcinomatosis
description
im Januar 2000 veröffentlichter wissenschaftlicher Artikel
@de
wetenschappelijk artikel
@nl
наукова стаття, опублікована в січні 2000
@uk
name
Expression of costimulatory mo ...... s of peritoneal carcinomatosis
@en
Expression of costimulatory mo ...... s of peritoneal carcinomatosis
@nl
type
label
Expression of costimulatory mo ...... s of peritoneal carcinomatosis
@en
Expression of costimulatory mo ...... s of peritoneal carcinomatosis
@nl
prefLabel
Expression of costimulatory mo ...... s of peritoneal carcinomatosis
@en
Expression of costimulatory mo ...... s of peritoneal carcinomatosis
@nl
P2093
P2860
P1476
Expression of costimulatory mo ...... s of peritoneal carcinomatosis
@en
P2093
B Melichar
C D Platsoucas
R S Freedman
P2860
P356
10.1046/J.1365-2249.2000.01105.X
P407
P577
2000-01-01T00:00:00Z